Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: Safety & Efficacy of Qurs e Fishar in Mild to Moderate Hypertensive Patients in Pakistan [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Qurs e Fishar for hypertension in Pakistan is currently recruiting; the study has not reported results yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qurs e Fishar

Snippet

Sponsor: Abdul Bari | Conditions: Hypertension | Phase 3 | Status: RECRUITING